2017
DOI: 10.3390/ijms18030659
|View full text |Cite
|
Sign up to set email alerts
|

Dysfunctional mTORC1 Signaling: A Convergent Mechanism between Syndromic and Nonsyndromic Forms of Autism Spectrum Disorder?

Abstract: Whereas autism spectrum disorder (ASD) exhibits striking heterogeneity in genetics and clinical presentation, dysfunction of mechanistic target of rapamycin complex 1 (mTORC1) signaling pathway has been identified as a molecular feature common to several well-characterized syndromes with high prevalence of ASD. Additionally, recent findings have also implicated mTORC1 signaling abnormalities in a subset of nonsyndromic ASD, suggesting that defective mTORC1 pathway may be a potential converging mechanism in ASD… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
29
0
4

Year Published

2017
2017
2023
2023

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 44 publications
(34 citation statements)
references
References 274 publications
1
29
0
4
Order By: Relevance
“…). This notion is supported by evidence that neurological disorders such as autism spectrum disorders are associated with dysfunctional mTOR signaling and represent an early pathological marker and a promising therapeutic target . For example, decreased mTOR signaling is detected in the brain of an animal model of Rett syndrome before the manifestation of neurological signs of the disease .…”
Section: Discussionmentioning
confidence: 91%
“…). This notion is supported by evidence that neurological disorders such as autism spectrum disorders are associated with dysfunctional mTOR signaling and represent an early pathological marker and a promising therapeutic target . For example, decreased mTOR signaling is detected in the brain of an animal model of Rett syndrome before the manifestation of neurological signs of the disease .…”
Section: Discussionmentioning
confidence: 91%
“…All these changes, together with the enrichment of the mTORC2 downstream signalling pathway, suggest that abnormal expression of PARK7 and GAP-43 might be a result of the dysregulation of the mTOR pathway in the PPS model. Indeed, the mTOR pathway has been shown to be involved in many neurological disorders, such as autism spectrum disorders 47,48 , Alzheimer's disease, tuberous sclerosis complex 46,49,50 , focal cortical dysplasia 51,52 and, more recently, intractable epilepsy 49,[53][54][55][56][57][58] . The mTORC1 and mTORC2 complexes are also upregulated in tissue from patients with MTLE 59 .…”
Section: Discussionmentioning
confidence: 99%
“…Studying rare mutations has proven to be valuable in identifying common pathways implicated in autism (Berg and Geschwind 2012;Willsey et al 2013). Our work has connected RAB39b mutation-associated macrocephaly/autism with PI3K-AKT-mTOR signaling, a convergent pathway implicated in ASD pathology across divergent etiologies (Huber et al 2015;Magdalon et al 2017). RAB39b interacts with PI3K components p85α and p110α, and its deletion promotes PI3K-AKT-mTOR signaling activity in human NPCs, cerebral organoids, and mouse cortex.…”
Section: Early Neurodevelopmental Dysregulation In Macrocephaly/autismentioning
confidence: 95%